The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Gener­ic drug in­dus­try push­es FDA to ad­dress ni­trosamine im­pu­ri­ties in a new way

3 years ago

No­var­tis cuts 275 jobs at Illi­nois site to con­sol­i­date Zol­gens­ma man­u­fac­tur­ing in North Car­oli­na

3 years ago
People
Pharma

FDA warns Bris­tol My­ers Squibb for im­prop­er­ly in­ves­ti­gat­ing con­t­a­m­i­na­tion at site that makes Abrax­ane

3 years ago
FDA+

Texas CD­MO is cut­ting 60% of staff as fo­cus shifts to drug dis­cov­ery, in-house can­di­dates

3 years ago
Pharma

Man­u­fac­tur­ing roundup: Teru­mo Phar­ma­ceu­ti­cal So­lu­tions ex­pand­ing CD­MO reach out­side Japan; EU­ROAPI boost­ing pro­duc­tion at Frank­furt site

3 years ago

#CPHI22: UPS Health­care sounds off on the fu­ture and chal­lenges of the sup­ply chain

3 years ago

FDA warn­ing let­ters de­tail is­sues for man­u­fac­tur­ing sites in the US and In­dia

3 years ago
Pharma
FDA+

Al­lo­gene Over­land Bio­pharm com­pletes Shang­hai fa­cil­i­ty to man­u­fac­ture CAR-T prod­ucts

3 years ago
Pharma
Cell/Gene Tx

#CPHI22: As Sam­sung’s new plant comes on­line, it looks to ex­pand in Ko­rea and be­yond

3 years ago
Pharma

#CPHI22: End­points sits down with con­fer­ence ex­ec as the man­u­fac­tur­ing world says ‘Guten Tag’ to CPHI

3 years ago

#CPHI22: Con­tract man­u­fac­tur­ers will still be nav­i­gat­ing glob­al chal­lenges in­to next year

3 years ago
Outsourcing

#CPHI22: An­nu­al re­port shows ‘mod­er­ate out­look’ and fo­cus on mR­NA

3 years ago

#CPHI22: A look back at the biggest man­u­fac­tur­ing projects in 2022

3 years ago

#CPHI22: Sup­ply chain woes are still bear­ing down on man­u­fac­tur­ers

3 years ago

FDA to kick off CMC readi­ness pi­lot pro­gram next April

3 years ago
Pharma
FDA+

Up­dat­ed: A short­age of amox­i­cillin is now be­ing re­port­ed by sev­er­al man­u­fac­tur­ers

3 years ago
Pharma

Cu­ria breaks ground on $100M ex­pan­sion project in New Mex­i­co

3 years ago
Pharma

Man­u­fac­tur­ing roundup: Symeres buys CRO in New Jer­sey; Cam­brex in­vests $16M+ in Min­neso­ta and Iowa fa­cil­i­ties

3 years ago
R&D

GSK puts a 'force ma­jeure’ on the man­u­fac­tur­ing of a pain med­i­cine in Pak­istan

3 years ago
Pharma

Eli Lil­ly com­mits $92M+ to Pur­due Uni­ver­si­ty to es­tab­lish phar­ma man­u­fac­tur­ing schol­ar­ship pro­gram

3 years ago
Pharma

Fu­ji­film Diosynth breaks ground on $300M ex­pan­sion project in Texas

3 years ago
Pharma

In­di­an site for Ju­bi­lant Gener­ics lands Form 483 for QC is­sues

3 years ago
Pharma

Au­robindo Phar­ma’s US branch is­sues a re­call of a gener­ic med­i­cine

3 years ago
Pharma
FDA+

Up­dat­ed: Con­t­a­m­i­na­tion is­sues lead to FDA warn­ing let­ter for South Car­oli­na man­u­fac­tur­ing fa­cil­i­ty

3 years ago
Pharma
FDA+
First page Previous page 41424344454647 Next page Last page
A service from the Financial Times